Boston-based Dana-Farber Cancer Institute has launched the Center for RAS Therapeutics, aiming to study and develop drug therapies for RAS-driven cancers.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis
Dana-Farber launches gene therapeutics center
